Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 92

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 92
---
-employee directors are compensated for their service as directors, including as members of the various Board committees:

Annual retainer

| All members                                                 |     |             $60,000 |
| Chair of the Board                                          |     | $120,000 additional |
| Chair of the Audit and Finance Committee                    |     |  $28,000 additional |
| Chair of the Compensation and Human Capital Committee       |     |  $20,000 additional |
| Chair of the Nominating and Governance Committee            |     |  $20,000 additional |
| Chair of the Research and Product Innovation Committee      |     |  $28,000 additional |
| Members of the Audit and Finance Committee(1)               |     |  $13,500 additional |
| Members of the Compensation and Human Capital Committee(1)  |     |  $10,000 additional |
| Members of the Nominating and Governance Committee(1)       |     |  $10,000 additional |
| Members of the Research and Product Innovation Committee(1) |     |  $13,500 additional |
| (1) Other than the chairperson of such committee            |     |                     |

Attendance

Non-employee directors do not receive any fees (other than the retainers outlined above) for attending Board or committee meetings. However, all directors are reimbursed for their out-of-pocket expenses incurred in attending Board and committee meetings.

Equity Awards

Under our 2017 Plan, our non-employee directors may receive an award of equity in the Company. As recommended and determined by our CHCC, and approved by our Board, we may grant to each non-employee director equity awards under the 2017 Plan upon his or her initial appointment to the Board. In addition, we may grant to each non-employee director equity awards on the date of each annual meeting of stockholders; provided, however, that (a) if a director is appointed to the Board within three months of the date of the next annual meeting of stockholders, such director will not receive an additional equity award on the date of the next annual meeting of stockholders, and (b) if a director is appointed to the Board between three and twelve months prior to the next annual meeting of stockholders, such director will receive a prorated equity award, rounded down on a quarterly basis, on the date of the next annual meeting of stockholders. Except in the case of a prorated equity award, the number of shares of restricted stock, restricted